Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Lipitor"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Lipitor."

8 result(s) displayed (1 - 8 of 8)


Omthera IPO adds big fish to heart drug pond

Company looks to capture market share from Glaxo and Amarin with Epanova medicine. Continue reading

Posted on March 12, 2013 9:20 AM




$9B to $10B Nestlé-Pfizer deal looks close

A sale of the nutrition business could be announced as soon as next week. Continue reading

Posted on April 18, 2012 12:46 PM




Watson chief hinted at large acquisition

Rumors swirl of a deal for Actavis Group amid solid rationales for a deal. Continue reading

Posted on March 22, 2012 3:50 PM




Watson Pharma chief: more acquisitions

CEO Paul Bisaro says the pharma will seek balance through M&A Continue reading

Posted on January 12, 2012 12:42 PM




Pfizer chief sets sights on smaller targets

The company, once known for megamergers, is now focusing on the middle market Continue reading

Posted on January 10, 2012 4:29 PM




Biotech milestones, blockbusters and orphans

In 2011, risk sharing returned to dealmaking in the sector as overconfidence left the market. Continue reading

Posted on December 9, 2011 12:00 PM




Big Pharma: Pfizer, Merck, Wyeth and more

The pharmaceutical industry has seen a ton of deals over the past few years, some $230 billion in M&A activity from the top 10 pharmaceutical companies alone since the beginning of 2007. Continue reading

Posted on March 9, 2010 9:13 AM




That's a spicy meatball

Skepticism abounds over Pfizer's ability to digest Wyeth. Continue reading

Posted on April 17, 2009 1:18 PM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors